With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
In the fourth quarter, Repligen's performance was mixed. Adjusted earnings per share (EPS) surpassed analysts' expectations ...
Seer (SEER) will showcase new findings at the 21st Annual US Human Proteome Organization – HUPO – Conference in Philadelphia from February ...
Jonathan Edelman, senior vice president of CSL’s vaccines innovation unit, said the approval “marks a significant milestone” ...
Additional presentations from Seer and collaborators will highlight the Proteograph Product Suite’s role in deep proteomic studies to understand tissue biology, uncover biomarkers for cardiometabolic ...
Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...
Hosted on MSN2d
Novavax to Report Q4 Earnings: Here's What You Can ExpectNovavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, ...
The company will discontinue development of its original ALS gene therapy candidate VY9323 amid toxic effects in nonhuman ...
The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) was the recipient of unusually large options trading on Tuesday. Stock investors bought 179,268 call options on the company. This represents an increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback